Octreotide acetate long-acting formulation versus open-label subcutaneous octreotide acetate in malignant carcinoid syndrome.
J Clin Oncol
; 17(2): 600-6, 1999 Feb.
Article
in En
| MEDLINE
| ID: mdl-10080605
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Gastrointestinal Agents
/
Octreotide
/
Malignant Carcinoid Syndrome
Type of study:
Clinical_trials
/
Observational_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Clin Oncol
Year:
1999
Document type:
Article
Affiliation country:
United States